Back to HomeBeta

ICD-10 Coding for Elevated Hematocrit(D64.9, D65.9, R71.8)

Complete ICD-10-CM coding and documentation guide for Elevated Hematocrit. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

High HematocritPolycythemia

Related ICD-10 Code Ranges

Complete code families applicable to Elevated Hematocrit

D64-D69Primary Range

Other disorders of blood and blood-forming organs

Includes codes for polycythemia vera and secondary polycythemia, which are common causes of elevated hematocrit.

Abnormal findings on examination of blood, without diagnosis

Includes codes for unspecified abnormalities of blood, such as elevated hematocrit without a known cause.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D64.9Anemia, unspecifiedUse when polycythemia vera is confirmed as the cause of elevated hematocrit.
  • JAK2 mutation positive
  • Splenomegaly
  • Bone marrow biopsy showing hypercellularity
D65.9Secondary polycythemiaUse when elevated hematocrit is due to secondary causes like COPD.
  • Oxygen saturation <92%
  • Presence of chronic hypoxia or COPD
R71.8Other abnormality of red blood cellsUse when elevated hematocrit is present without a confirmed cause.
  • Elevated hematocrit with no identified cause after workup

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for elevated hematocrit

Essential facts and insights about Elevated Hematocrit

The ICD-10 code for elevated hematocrit varies based on the cause: D64.9 for polycythemia vera, D65.9 for secondary causes.

Primary ICD-10-CM Codes for elevated hematocrit

Anemia, unspecified
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed JAK2 mutation and clinical symptoms of polycythemia vera.

Applicable To

  • Polycythemia vera

Excludes

  • Secondary polycythemia (D65.9)

Clinical Validation Requirements

  • JAK2 mutation positive
  • Splenomegaly
  • Bone marrow biopsy showing hypercellularity

Code-Specific Risks

  • Incorrect use without JAK2 mutation confirmation

Coding Notes

  • Ensure JAK2 mutation and other clinical indicators are documented.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Other abnormality of red blood cells

R71.8
Use when elevated hematocrit is present without a confirmed cause.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Secondary polycythemia

D65.9
Presence of underlying conditions like COPD or chronic hypoxia.

Polycythemia vera

D64.9
JAK2 mutation and absence of secondary causes.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Elevated Hematocrit to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D64.9.

Impact

Clinical: Potential misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Denied claims due to insufficient documentation.

Mitigation Strategy

Ensure JAK2 mutation testing is performed and documented., Review lab results before coding.

Impact

Reimbursement: Incorrect DRG assignment leading to potential revenue loss., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient care.

Mitigation Strategy

Use D64.9 for polycythemia vera or D65.9 for secondary causes.

Impact

Using R71.8 instead of a specific cause code.

Mitigation Strategy

Review clinical documentation to ensure specific cause is identified.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Elevated Hematocrit, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Elevated Hematocrit

Use these documentation templates to ensure complete and accurate documentation for Elevated Hematocrit. These templates include all required elements for proper coding and billing.

Polycythemia vera management

Specialty: Hematology

Required Elements

  • JAK2 mutation status
  • Hematocrit levels
  • Bone marrow biopsy results

Example Documentation

Patient with polycythemia vera (D64.9) presents for therapeutic phlebotomy. HCT 56%, JAK2+, no thrombotic history.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has high hematocrit.
Good Documentation Example
Patient presents with elevated hematocrit (52%) confirmed on CBC, JAK2 V617F mutation positive, consistent with polycythemia vera.
Explanation
The good example provides specific lab results and a confirmed diagnosis, supporting accurate coding.

Need help with ICD-10 coding for Elevated Hematocrit? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more